Boston Scientific Corp. (BSX)
43.64
+0.61
(+1.42%)
USD |
NYSE |
Nov 18, 16:00
43.45
-0.19
(-0.44%)
Pre-Market: 07:48
Boston Scientific Net Income (Quarterly) : 580.00M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 580.00M |
| June 30, 2026 | 905.00M |
| March 31, 2026 | 1.339B |
| December 31, 2025 | 670.00M |
| September 30, 2025 | 755.00M |
| June 30, 2025 | 795.00M |
| March 31, 2025 | 672.00M |
| December 31, 2024 | 562.00M |
| September 30, 2024 | 468.00M |
| June 30, 2024 | 322.00M |
| March 31, 2024 | 493.00M |
| December 31, 2023 | 504.00M |
| September 30, 2023 | 504.00M |
| June 30, 2023 | 270.00M |
| March 31, 2023 | 314.00M |
| December 31, 2022 | 140.00M |
| September 30, 2022 | 188.00M |
| June 30, 2022 | 260.00M |
| March 31, 2022 | 111.00M |
| December 31, 2021 | 94.00M |
| September 30, 2021 | 419.00M |
| June 30, 2021 | 186.00M |
| March 31, 2021 | 341.00M |
| December 31, 2020 | 152.00M |
| September 30, 2020 | -155.00M |
| Date | Value |
|---|---|
| June 30, 2020 | -147.00M |
| March 31, 2020 | 11.00M |
| December 31, 2019 | 3.996B |
| September 30, 2019 | 126.00M |
| June 30, 2019 | 154.00M |
| March 31, 2019 | 424.00M |
| December 31, 2018 | 386.00M |
| September 30, 2018 | 432.00M |
| June 30, 2018 | 555.00M |
| March 31, 2018 | 298.00M |
| December 31, 2017 | -615.00M |
| September 30, 2017 | 283.00M |
| June 30, 2017 | 146.00M |
| March 31, 2017 | 290.00M |
| December 31, 2016 | 124.00M |
| September 30, 2016 | 228.00M |
| June 30, 2016 | -207.00M |
| March 31, 2016 | 202.00M |
| December 31, 2015 | -142.00M |
| September 30, 2015 | -198.00M |
| June 30, 2015 | 102.00M |
| March 31, 2015 | -1.00M |
| December 31, 2014 | -299.00M |
| September 30, 2014 | 43.00M |
| June 30, 2014 | 4.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| Becton, Dickinson & Co. | 696.00M |
| Stryker Corp. | 753.00M |
| Insulet Corp. | 141.10M |
| The Cooper Cos., Inc. | 432.80M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.138B |
| Total Expenses (Quarterly) | 4.556B |
| EPS Diluted (Quarterly) | 0.4008 |
| Enterprise Value | 74.78B |
| Gross Profit Margin (Quarterly) | 62.20% |
| Profit Margin (Quarterly) | 11.29% |
| Earnings Yield | 5.41% |
| Operating Earnings Yield | 7.00% |
| Normalized Earnings Yield | 5.844 |